## Abstract For studies of pharmacokinetics and drug metabolism of the new 5‐HT~1A~ agonist repinotan, the ^14^C‐labelled version was synthesized. Starting from [U‐^14^C]phenol, a 10‐step synthesis led to 457 mg (1.58 GBq) of [U‐^14^C]repinotan hydrochloride, labelled uniformly in the aromatic ring
A short synthesis of [14C]-labelled levamisole and its major metabolite
✍ Scribed by Cor G.M. Janssen; Jos B.A. Thijssen; Willy L.M. Verluyten
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- French
- Weight
- 109 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0022-2135
- DOI
- 10.1002/jlcr.573
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Levamisole (I) is the levo isomer of tetramisole. It is a broad spectrum anthelmintic which is used extensively as a veterinary drug for food producing animals. Metabolism and environmental studies necessitated the synthesis of ^14^C‐labelled levamisole (6) and of its major metabolite (12).
^14^C‐Tetramisole was obtained in two steps from ^14^C‐thiourea. Resolution via salt formation and crystallization afforded ^14^C‐levamisole and ^14^C‐dexamisole. Racemisation followed again by resolution made it possible to improve the over‐all radiochemical yield of ^14^C‐levamisole to 51.0%. The compound had a specific activity of 73.6 MBq/mmol, a HPLC purity of 99.8% and an enantiomeric excess of 99.4%.
The ^14^C‐labelled metabolite of levamisole (II) was obtained from ^14^C‐potassium cyanate in 4 consecutive steps. Resolution via chiral HPLC afforded the desired compound in a 16.2% overall radiochemical yield. It had a specific activity of 895 MBq/mmol, a HPLC purity of 98.7% and an enantiomeric excess of 100%. Copyright © 2002 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
The syntheses of '%-ring labeled levamisole ([-)-2,3,5,6-tetrahydr0-6-phenyl[~'C-UL]imidazo(Z, 1b]thiole) from acetophenone-ring-UL-l'C in 5 steps plus resolution with a 7.5% overall yield, and %,-ring labeled tetramisole ([i]-2,3,5,6-tetrahydro-6-phenyif3 S ]imidaz0[2,?-bjthiazole) from benzene-'%,
## Abstract Ambroxol is a mucolytic agent used in the treatment of respiratory diseases. Herein, we report the synthesis of carbon‐14‐labeled ambroxol with the radioactive atom(s) either on the benzylic carbon or uniformly in the cyclohexyl ring with specific activities of 59 and 81 mCi/mmol, respe
## Abstract For studies of pharmacokinetics and drug metabolism of the new orally active, selective phosphodiesterase type V (PDE V) inhibitor vardenafil (Levitra^®^), the ^14^C‐labelled version was synthesised. Starting from the cyanation of 2‐iodophenol with K^14^CN, an 8‐step synthesis led to tw
## Abstract The synthesis of two ^14^C‐labeled forms of prinomide, compounds 7 and 10, and the synthesis of a ^14^C‐labeled form of its hydroxy metabolite are described. Compound 7 was synthesized by the reaction of phenyl isocyanate and 1‐methyl‐β‐oxo‐pyrrole‐2‐propanenitrile‐carbonyl‐^14^C (6), w